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Summary. Osteogenesis is a complex process charac- 
terized sequentially by the committment of precursor 
cells, the proliferation of osteoprogenitor cells, the 
differentiation of pre-osteoblasts into mature osteoblasts 
and the apposition of a calcified bone matrix. Recent 
advances in cell and molecular biology have improved 
our knowledge of the cellular and molecular mecha- 
nisms controlling the different steps of bone formation in 
humans. Using ex vivolin vitro studies of disorders of 
bone formation, we showed that the recruitment of 
osteoprogenitor cel ls  is  the most important s tep  
controlling the rate of bone formation in both rodents 
and humans. Accordingly, treatments stimulating 
osteoblast recruitment were found to increase bone 
formation in experimental models of osteopenic 
disorders. Using models of human osteoblastic cells, we 
identified the profile of phenotypic markers expressed 
during osteoblast differentiation, and found that 
hormones and growth factors control osteoblastic cell 
proliferation and differentiation in a sequential and 
coordinate manner during osteogenesis in vitro. Our 
recent evaluation of the phenotypic osteoblast ab- 
normalities induced by genetic mutations in the G,a and 
FGFR-2 genes led to the characterization of the role of 
these genes in the alterations of osteoblast proliferation 
and differentiation in humans. These studies at the 
histological, cellular and molecular levels provided new 
insight into the mechanisms that are involved in 
pathological bone formation in humans. It is expected 
that further determination of the pathogenic pathways in 
metabolic and genetic abnormalities in human 
osteoblasts will help to identify novel target genes and to 
conceive new therapeutic tools to stimulate bone 
formation in osteopenic disorders. 
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Introduction 
Bone formation is a complex process which involves 
interactions between cells of the osteoblastic lineage, 
bone matrix proteins and a variety of local regulatory 
factors. At the histological level, endosteal bone 
formation sites appear as complex structures composed 
of a calcified and uncalcified bone matrix synthesized by 
mature osteoblasts (Fig. 1). This structure results from 
complex sequential events involving the recruitment of 
competent cells, the differentiation into committed cells 
and the adequate function of mature osteoblasts at the 
right time and space. The formation of bone matrix 
requires, therefore, the coordination of several 
mechanisms controlling cell  function and matrix 
formation. In addition, several interactions occur 
between marrow stromal cells, osteoblasts, the matrix 
itself and other bone cells, and the osteoblasts are 
believed to play a central role in the control of bone 
remodeling. Thus, abnormalities occuring during the 
recruitment or differentiationlactivity of bone forming 
cells may lead to local or generalized disorders of bone 
formation. 
For many years, my laboratory has developed 
studies to delineate the mechanisms controlling the 
biology and pathology of osteoblasts at the endosteal 
level. We initially used histological and histomorpho- 
metrical methods to analyze bone formation at the 
endosteal level. The general histological aspects of 
endosteal bone formation (Marie, 1982) and the 
regulation of endosteal osteoblasts by minerals,  
hormones and local factors have been previously 
reviewed (summarized in Marie et al., 1994). 
Approaches were then developed to investigate the 
cellular mechanisms controlling endosteal osteoblast 
differentiation and osteogenesis in animals and humans 
(for review, see Lomri and Marie, 1996; Marie, 1998). 
The aim of the present article was to review recent data 
on the cellular and molecular alterations of osteoblasts in 
human disorders of bone formation, based on data 
obtained in my laboratory and by other investigators. 
After having described the general methodological 
approaches used to study the osteoblast function, the 













